Parabilis Medicines, Inc. Cash and Cash Equivalents
Parabilis Medicines, Inc. (PBLS) had Cash and Cash Equivalents of $1.09 billion as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.09B.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $27.71M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $80.39M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-08-13 |
| 2025-12-31 | $27.71M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $80.39M 10-Q · filed 2026-08-13 |